Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 7.2 Million Yuan Net Loss in First Half of 2021

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net loss of 7.2 million yuan in the first half of 2021, reversing a net profit of 28.7 million yuan for the same period in the previous year.

Meanwhile, the company posted 183.3 million yuan in revenue, up 65.8% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 332.1 million yuan in total liabilities, with a liability-to-asset ratio of 17.9%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.